A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma

Background: Combination treatment with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) has been widely used in patients with unresectable hepatocellular carcinoma (uHCC). As no standard guidelines exist for second-line therapy after failure of combination treatment, this st...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Renguo Guan (Auteur), Chengyou Yu (Auteur), Shaohua Li (Auteur), Jie Mei (Auteur), Wei Wei (Auteur), Rongping Guo (Auteur)
Formaat: Boek
Gepubliceerd in: Frontiers Media S.A., 2022-09-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar